Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6281.5000 94.00 (1.52%)
NSE Feb 18, 2026 13:57 PM
Volume: 349.8K
 

logo
Divi's Laboratories Ltd.
24 Jul 2017
6281.50
1.52%
buy
by HDFC Securities
HDFC Securities
Revenue decreased by 23.01% to Rs. 821.2 Cr in Q1FY18 when compared to the previous quarter. Revenue decreased by 23.01% to Rs. 821.2 Cr in Q1FY18 when compared to the previous quarter.
 
Number of FII/FPI investors decreased from 897 to 868 in Dec 2025 qtr
More from Divi's Laboratories Ltd.
Recommended
Market trades flat, L&T partners with NVIDIA for AI factory
Trendlyne Marketwatch | 18 Feb 2026, 01:46PM
Five stocks to buy from analysts this week - February 17, 2026
The Baseline | 17 Feb 2026, 06:00PM
Custom synthesis business drives growth for Divi’s Laboratories
| 10 Mar 2022